TENAX THERAPEUTICS, INC. — Director's Dealing 2021

Jan 12, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TENAX THERAPEUTICS, INC. (TENX)
CIK: 0000034956
Period of Report: 2021-01-05

Reporting Person: DiTonno Anthony A (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-05	Stock option (right to buy)	$1.85	A	90000	Acquired	2031-01-05	Common stock (90000)	Direct